Live Breaking News & Updates on Montreal Hospital Center

Stay updated with breaking news from Montreal hospital center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Biother Radiopharm , Fred Saad , Julia Schulze , Dominik Ruettinger , Carolyn Nagle , Amitd Raval , Head Of Research , Surgery At University Of Montreal , Early Development For Oncology At Bayer , American Association Of Clinical Research Annual Meeting , American Association Of Cancer Research Annual Meeting , Genitourinary Oncology , Montreal Hospital Center , Early Development , New Drugs , American Association , Cancer Research , Accessed March , Clinical Research Annual Meeting , Ihr Portfolio ,

Quebec adds more virtual wards to increase at-home medical care - Montreal

The program allows people who have been hospitalized to go home sooner while still receiving care. Experts say it's a step in the right direction but not a one-stop solution. ....

Eveline Gaillardetz , Paul Brunet , Erin Cook , Gloria Henirquez , University Of Montreal Hospital Center , Mcgill University Health Centre , Jewish General Hospital , Mcgill University Health Centre , Montreal Hospital Center , Quebec Health Care ,

Automated Processing, EEG Algorithm Predicts 1-Year Seizure Recurrence in Patients

Predictions for identifying 1-year seizure recurrence performed significantly better in electroencephalography (EEG) without interictal epileptiform discharges.
....

University Of Montreal Hospital Center , Montreal Hospital Center ,

Link Between PSA Response and Survival Outcomes Supports Use of Darolutamide Plus ADT/Docetaxel as a SOC in mHSPC

Fred Saad, MD, FRCS, expands on the relationship between PSA responses and survival outcomes in the ARASENS trial, explained the use of 0.2 ng/mL as a standard cut off for undetectable PSA within this exploratory analysis, and discussed how this study elucidates future directions for research with triplet regimens in mHSPC. ....

United States , Fred Saad , Raymond Garneau , Montreal Cancer Institute , University Of Montreal Hospital Center , American Urological Association , University Of Montreal , Research Center , Department Of Surgery , Urological Association , Annual Meeting , Montreal Hospital Center , Montreal Cancer , Raymond Garneau Chair , Prostate Cancer , Arasens Trial , Psa Response , Survival Outcomes , Metastatic Hormone Sensitive Prostate Cancer , Triplet Regimens , Aua Meeting ,

Dr Saad on PSA Response and Time to PSA Progression With Abiraterone Acetate and Olaparib in mCRPC

Fred Saad, MD, FRCS, discusses prostate-specific antigen (PSA) response and time to PSA progression with the combination of abiraterone acetate and olaparib in patients with metastatic castration-resistant prostate cancer. ....

Raymond Garneau , Fred Saad , Department Of Surgery , Montreal Cancer Institute , University Of Montreal Hospital Center , University Of Montreal , Research Center , Prostate Cancer Working Group , Montreal Hospital Center , Montreal Cancer , Raymond Garneau Chair , Prostate Cancer ,